Company / Total Debt
Thermo Fisher Scientific Total Debt History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$39.2B
FY2025
5-year range
$31.1B / $39.2B
FY2021-FY2025
Trend
+26.1%
vs FY2024
Sector context
#3 of 100
Health Care
What the data says
Among 100 Health Care companies, Thermo Fisher Scientific is in the bottom 3% for total debt. Total Debt has fluctuated over the past 8 years, ranging from $17.8B in FY2019 to $39.2B in FY2025.
Based on SEC 10-K filings.
$39.2B in FY2025 with a 5-year CAGR of +12.5%. Ranks 3rd among 100 companies in Health Care.
Increased from $34.7B to $39.2B over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- +4.5%
- 5-Year CAGR
- +12.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 100This company $39.2B Sector average $4.6B
▼
+760.6% above sector average
Key checks
Key Insights
- 5-year CAGR of +12.5%, indicating consistent growth.
- In FY2025, total debt increased 26.1% year-over-year.
- Ranks #3 out of 100 companies in the Health Care sector.
- Lowest total debt in the period was in FY2019.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $39.2B | +26.1% |
| FY2024 | $31.1B | -10.5% |
| FY2023 | $34.7B | +1.3% |
| FY2022 | $34.3B | -1.1% |
| FY2021 | $34.7B | +59.6% |
| FY2020 | $21.7B | +22.4% |
| FY2019 | $17.8B | -6.5% |
| FY2018 | $19.0B | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026